Global Medicated Skin Care Products Strategic Business Report 2018: Medicated Skin Care Innovations Spearheading Growth - ResearchAndMarkets.com

The "Medicated Skin Care Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Medicated Skin Care Products in US$ Million.

Market Trends, Issues & Drivers

• Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth
• Health & Wellness Boosts Demand for Dermocosmetics
• Aging Population and their Vulnerability to Age-Related Skin Changes: A Strong Growth Driver
• Major Anti-Aging Ingredients of Cosmeceuticals
• Popular Cosmeceutical Demographic Statistics of the Global Aging Populace: Unfurling the Market Potential
• Booming Demand for Anti-Aging Skin Care Products Bodes Well for the Market
• Common Skin Care Cosmeceuticals
• Growing Prominence of Personalized Skin Care Prescriptions Benefit Market Penetration
• Failure of Non-Prescription Products Drive Demand for Physician-Dispensed Skin Care Solutions
• Medicated Skin Care Innovations: Spearheading Growth
• Innovations for Acne
• Innovations for Actinic Keratosis
• Innovations for Tuberous Sclerosis Complex and Angiofibromas
• Melasma Treatment Innovations
• Onychomycosis Treatment Innovations
• Innovations for Alopecia/Hair Loss
• Stem Cell Technology: The New Frontier?
• Intelligent Scanning for Identifying Beneficial Ingredients
• Innovations in Anti-Aging Skin Care
• Other Noteworthy Medicated Skin Care Innovations
• Consumer Interest in Natural Ingredients Drive Demand for Natural and Organic Products
• What's Next in Ingredients?
• Innovative Ingredients Gain Focus
• Aesthetic Dermatology to Witness Sustained Growth
• Favorable Trends in the Beauty Industry Spell Opportunities for Medicated Skin Care Market
• Surging Popularity of Multi-Functional Products Promote Market Expansion
• Sales of Hydroquinone-free Products Gain Momentum
• Facial Wipes Offers Huge Untapped Growth Potential
• Women: The Dominant Consumer Cluster for Medicated Skin Care Products
• Physiological Differences Entail Need for Male Specific Products
• Growing Prominence of Non-Invasive Skin Treatments Lends Traction to Market Demand
• Increasing Environmental Pollution Drive Demand for Anti- Pollution Skin Care Products
• Exponential Increase in Urban Population Promote Higher Demand for Medicated Skin Care

The report profiles 120 companies including many key and niche players such as:

• Advanced Dermatology Corporation (USA)
• Bayer AG (Germany)
• Beiersdorf AG (Germany)
• La Prairie Group AG (Switzerland)
• Chattem, Inc. (USA)
• Curatio Healthcare India Pvt. Ltd. (India)
• Dr. med. Christine Schrammek Kosmetik GmbH & Co. KG (Germany)
• EltaMD, Inc. (USA)
• Episciences, Inc. (USA)
• Galderma S.A. (Switzerland)
• GlaxoSmithKline Plc (UK)
• Stiefel Laboratories Inc. (USA)
• IntraDerm Pharmaceuticals (USA)
• Johnson & Johnson (USA)
• Kao Corporation (Japan)
• Laboratorios Leti SL. (Spain)
• L'Oral S.A. (France)
• Medimetriks Pharmaceuticals, Inc. (USA)
• Merz Pharma GmbH & Co. KGaA (Germany)
• NEOCUTIS (USA)
• Otsuka Pharmaceutical Co., Ltd. (Japan)
• PCA Skin (USA)
• Pfizer Inc. (USA)
• Prestige Brands (USA)
• Shiseido Co., Ltd. (Japan)
• RVive Skincare (USA)
• SkinCeuticals (USA)
• SkinMedica, Inc. (USA)
• Skinvisible Pharmaceuticals, Inc. (USA)
• Taisho Pharmaceuticals Co., Ltd. (Japan)
• The Himalaya Drug Company (India)
• Unilever NV (Netherlands)
• Valeant Pharmaceuticals International, Inc. (Canada)
• Obagi Medical Products, Inc. (USA)
• ZO Skin Health Inc. (USA)

Key Topics Covered:

1. Industry Overview

2. Market Trends, Issues & Drivers

3. Regulatory Framework

4. Product Overview

5. Product Launches/Approvals

6. Recent Industry Activity

7. Focus On Select Global Players

8. Global Market Perspective

Total Companies Profiled: 120 (including Divisions/Subsidiaries 127)

• The United States (58)
• Canada (3)
• Japan (11)
• Europe (45)
  • France (7)
  • Germany (8)
  • The United Kingdom (8)
  • Spain (1)
  • Rest of Europe (21)
• Asia-Pacific (Excluding Japan) (10)
  

For more information about this report visit https://www.researchandmarkets.com/research/n2b2rl/global_medicated?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180809005384/en/